Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,114
-$1,539,194 QoQ
Shares Held
1,692
-94.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,085
of 1,348 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$9,588
CallShares
200
PutValue
$2,114,154
PutShares
44,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names. NVO ranks #6 (0.6% of the industry book) .
All Filings in NVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,114,154 | 44,100 | Put | Sole | 2026-08-13 | |
| 2026-06-30 | $9,588 | 200 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $81,114 | 1,692 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $5,682,176 | 102,400 | Call | Sole | 2025-11-17 | |
| 2025-09-30 | $1,620,308 | 29,200 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||